To review overall survival (OS), recurrence patterns, and prognostic factors of de novo sinonasal squamous cell carcinoma (DN-SCC).
Data Sources
PubMed, Scopus, OVID Medline, and Cochrane databases from 2006 to December 23, 2020.
Review Methods
The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Articles were required to report either recurrence patterns or survival outcomes of adults with DN-SCC. Case reports, books, reviews, meta-analyses, and database studies were all excluded.
Results
Forty-one studies reported on survival or recurrence outcomes. The aggregate 5-year OS was 54.5% (range, 18%-75%) from 35 studies (n = 1903). Patients undergoing open surgery were more likely to receive radiation therapy and present at an advanced stage compared to those receiving endoscopic surgery (all P < .001). Advanced T stage, presence of cervical nodal metastases, maxillary sinus primary site, and negative human papillomavirus (HPV) status were all correlated with significantly worse 5-year OS. Direct meta-analysis of 8 studies demonstrated patients with surgery were more likely to be alive at 5 years compared to those who did not receive surgery (odds ratio, 2.26; 95% CI, 1.48-3.47; P < .001). Recurrence was reported in 628 of 1471 patients from 26 studies (42.7%) with an aggregate 5-year locoregional control rate of 67.1% (range, 50.4%-93.3%).
Conclusion
This systematic review and meta-analysis suggests that the 5-year OS rate for DN-SCC may approach 54.5% and recurrence rate approaches 42.7%. In addition, various tumor characteristics including advanced T stage, positive nodal status, maxillary sinus origin, and negative HPV status are all associated with decreased survival.
DuttaRDubalPMSviderPFLiuJKBaredesSEloyJA.Sinonasal malignancies: a population-based analysis of site-specific incidence and survival. Laryngoscope. 2015;125(11):2491-2497.
2.
TurnerJHRehDD.Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877-885.
3.
JainSLiYKuanECTajudeenBABatraPS.Prognostic factors in paranasal sinus squamous cell carcinoma and adenocarcinoma: a SEER database analysis. J Neurol Surg B Skull Base. 2019;80(3):258-263.
4.
JanikSGrambergerMKadletzLPammerJGraslMCErovicBM.Impact of anatomic origin of primary squamous cell carcinomas of the nasal cavity and ethmoidal sinus on clinical outcome. Eur Arch Otorhinolaryngol. 2018;275(9):2363-2371.
5.
RobinTPJonesBLGordonOM, et al. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer. 2017;123(16):3040-3049.
6.
RussoALAdamsJAWeymanEA, et al. Long-term outcomes after proton beam therapy for sinonasal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2016;95(1):368-376.
7.
CohenECovielloCMenakerS, et al. P16 and human papillomavirus in sinonasal squamous cell carcinoma. Head Neck. 2020;42(8):2021-2029.
8.
de AlmeidaJRSuSYKoutourousiouM, et al. Endonasal endoscopic surgery for squamous cell carcinoma of the sinonasal cavities and skull base: oncologic outcomes based on treatment strategy and tumor etiology. Head Neck. 2015;37(8):1163-1169.
9.
YanCHNewmanJGKennedyDWPalmerJNAdappaND.Clinical outcomes of sinonasal squamous cell carcinomas based on tumor etiology. Int Forum Allergy Rhinol. 2017;7(5):508-513.
10.
LiYWangCWangR, et al. Prognostic factors of sinonasal squamous cell carcinomas arising de novo and from inverted papilloma. Am J Rhinol Allergy. 2021;35(1):114-121.
11.
QuanHZhangHZouLYuanWWangS.Comparison of outcomes between patients with de-novo sinonasal squamous cell carcinoma vs malignant transformations from inverted papillomas. Int Forum Allergy Rhinol. 2020;10(6):762-767.
12.
ElgartKFadenDL.Sinonasal squamous cell carcinoma: etiology, pathogenesis, and the role of human papilloma virus. Curr Otorhinolaryngol Rep. 2020;8(2):111-119.
13.
LewisJSJr.Sinonasal squamous cell carcinoma: a review with emphasis on emerging histologic subtypes and the role of human papillomavirus. Head Neck Pathol. 2016;10(1):60-67.
14.
ChowdhuryNAlviSKimuraK, et al. Outcomes of HPV-related nasal squamous cell carcinoma. Laryngoscope. 2017;127(7):1600-1603.
15.
HommaANakamaruYSakashitaT, et al. Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: a single institution experience. Ausis Nasus Larynx. 2015;42(5):377-381.
16.
JangNYWuH-GParkCIl, et al. definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity. Jpn J Clin Oncol. 2010;40(6):542-548.
17.
KanoSHayashiRHommaA, et al. Effect of local extension sites on survival in locally advanced maxillary sinus cancer. Head Neck. 2014;36(11):1567-1572.
18.
LiRTianSZhuYZhuWWangS.Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years’ experience. Int Forum Allergy Rhinol. 2020;10(2):243-255.
19.
MoherDLiberatiATetzlaffJAltmanDGGroupP.Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
20.
ScurryWCJrGoldenbergDCheeMYLengerichEJLiuYFedokFG.Regional recurrence of squamous cell carcinoma of the nasal cavity: a systematic review and meta-analysis. Arch Otolaryngol Neck Surg. 2007;133(8):796-800.
21.
SlimKNiniEForestierDKwiatkowskiFPanisYChipponiJ.Methodological Index for Non-Randomized Studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-716.
22.
Review Manager Web (Rev Man Web). The Cochrane Collaboration. Published 2019. Accessed December 18, 2020. revman.cochrane.org
23.
ArnoldAZiglinasPOchsK, et al. Therapy options and long-term results of sinonasal malignancies. Oral Oncol. 2012;48(10):1031-1037.
24.
BobinskasAWiesenfeldDChanduA.Influence of the site of origin on the outcome of squamous cell carcinoma of the maxilla—oral versus sinus. Int J Oral Maxillofac Surg. 2014;43(2):137-141.
25.
BrownJSBekirogluFShawRJWoolgarJATriantafyllouARogersSN.First report of elective selective neck dissection in the management of squamous cell carcinoma of the maxillary sinus. Br J Oral Maxillofac Surg. 2013;51(2):103-107.
26.
Castelnau-MarchandPLevyAMoya-PlanaA, et al. Sinonasal squamous cell carcinoma without clinical lymph node involvement. Strahlenther Onkol. 2016;192(8):537-544.
27.
ChoiIJKimD-WKimD-YLeeCHRheeC-S.Predictive markers for neoadjuvant chemotherapy in advanced squamous cell carcinoma of maxillary sinus: preliminary report. Acta Otolaryngol. 2013;133(3):291-296.
28.
ChenNChenLWangJ, et al. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus. Jpn J Clin Oncol. 2016;46(8):727-734.
29.
DaleOTPringMDaviesA, et al. Squamous cell carcinoma of the nasal cavity: a descriptive analysis of cases from the head and neck 5000 study. Clin Otolaryngol. 2019;44(6):961-967.
30.
Duru BirgiSTeoMDykerKESenMPrestwichRJD.Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience. Radiat Oncol. 2015;10(1):190.
31.
EbaraTAndoKEishimaJ, et al. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma. Jpn J Radiol. 2019;37(6):494-499.
32.
GuanXWangXLiuYHuCZhuG.Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT. Oral Oncol. 2013;49(1):60-65.
33.
HinermanRWIndelicatoDJMorrisCG, et al. Radiotherapy with or without surgery for maxillary sinus squamous cell carcinoma: should the clinical N0 neck be treated?Am J Clin Oncol. 2011;34(5):483-487.
34.
HirakawaHHanaiNOzawaT, et al. Prognostic impact of pathological response to neoadjuvant chemotherapy followed by definitive surgery in sinonasal squamous cell carcinoma. Head Neck. 2016;38(S1):E1305-E1311.
35.
HommaASakashitaTYoshidaD, et al. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer. 2013;109(12):2980-2986.
36.
KanekoTTadaYMaruyaS, et al. Intra-arterial chemoradiation therapy with weekly low-dose cisplatin for squamous cell carcinoma of the maxillary sinus. Int J Oral Maxillofac Surg. 2015;44(6):697-704.
37.
KermerCPoeschlPWWutzlASchopperCKlugCPoeschlE.Surgical treatment of squamous cell carcinoma of the maxilla and nasal sinuses. J Oral Maxillofac Surg. 2008;66(12):2449-2453.
38.
KimJHLeeYSChungY-S, et al. Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: a single-institution study. Acta Otolaryngol. 2015;135(11):1189-1195.
39.
KondoAKuroseMObataK, et al. A clinical study of maxillary sinus squamous cell carcinoma. Adv Otorhinolaryngol. 2016;77:83-87.
40.
KreeftAMSmeeleLERaschCRN, et al. Preoperative imaging and surgical margins in maxillectomy patients. Head Neck. 2012;34(11):1652-1656.
41.
MichelJFakhryNManciniJ, et al. Sinonasal squamous cell carcinomas: clinical outcomes and predictive factors. Int J Oral Maxillofac Surg. 2014;43(1):1-6.
42.
NakamaruYSuzukiMKanoS, et al. The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma. Auris Nasus Larynx. 2021;48(1):131-137.
43.
OckC-YKeamBKimTM, et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med. 2016;31(3):570-578.
44.
OnoTTanakaNUmenoH, et al. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: implications for prognostic factors. J Craniomaxillofacial Surg. 2017;45(12):2128-2134.
45.
OnoTTanakaNUmenoH, et al. Treatment outcomes of locally advanced squamous cell carcinoma of the ethmoid sinus treated with anterior craniofacial resection or chemoradiotherapy. Case Rep Oncol. 2017;10(1):339-349.
46.
ParéABlanchardPRoselliniS, et al. Outcomes of multimodal management for sinonasal squamous cell carcinoma. J Craniomaxillofacial Surg. 2017;45(8):1124-1132.
47.
ParkS-HLeeJEAhnD.Outcome of definitive and postoperative radiotherapy in patients with sinonasal squamous cell carcinomas. Tumori J. 2015;102(4):426-432.
48.
SakashitaTHayashiRHommaA, et al. Multi-institutional retrospective study for the evaluation of ocular function—preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion. Head Neck. 2015;37(4):537-542.
49.
SantosMRMServatoJPSCardosoSV, et al. Squamous cell carcinoma at maxillary sinus: clinicopathologic data in a single Brazilian institution with review of literature. Int J Clin Exp Pathol. 2014;7(12):8823-8832.
50.
ToyomasuYDemizuYMatsuoY, et al. Outcomes of patients with sinonasal squamous cell carcinoma treated with particle therapy using protons or carbon ions. Int J Radiat Oncol Biol Phys. 2018;101(5):1096-1103.
51.
WangYYangRZhaoM, et al. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration. World J Surg Oncol. 2020;18(1):90.
52.
WangZQuYWangK, et al. The value of preoperative radiotherapy in the treatment of locally advanced nasal cavity and paranasal sinus squamous cell carcinoma: a single institutional experience. Int J Radiat Oncol Biol Phys. 2019;105(1):E387.
53.
YasumatsuRJiromaruRHongoT, et al. A clinical analysis of sinonasal squamous cell carcinoma: a comparison of de novo squamous cell carcinoma and squamous cell carcinoma arising from inverted papilloma. Acta Otolaryngol. 2020;140(8):698-703.
54.
RestoVAChanAWDeschlerDGLinDT.Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck. 2008;30(2):222-229.
55.
QiuXYangJ.Clinical study of cetuximab combined with radical radiotherapy in the treatment of locally advanced sinonasal squamous cell carcinoma. J BUON. 2018;23(4):1111-1117.
56.
JethanamestDMorrisLGSikoraAGKutlerDI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276-280.
57.
KuanECArshiAMallen-St ClairJTajudeenBAAbemayorESt JohnMA.Significance of tumor stage in sinonasal undifferentiated carcinoma survival: a population-based analysis. Otolaryngol Neck Surg. 2016;154(4):667-673.
58.
MirzaSBradleyPJAcharyaAStaceyMJonesNS.Sinonasal inverted papillomas: recurrence, and synchronous and metachronous malignancy. J Laryngol Otol. 2007;121(9):857-864.
59.
YuMSLimWSLeeB-JChungY-S.Squamous cell carcinoma associated with inverted papilloma of the maxillary sinus: our experience with 21 patients. Clin Otolaryngol. 2017;42(5):1048-1052.
60.
LeeJJPetersonAMEmbryTW, et al. Survival outcomes of de novo vs inverted papilloma–associated sinonasal squamous cell carcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Neck Surg. 2021;147(4):350-359.
61.
UnsalAADubalPMPatelTD, et al. Squamous cell carcinoma of the nasal cavity: a population-based analysis. Laryngoscope. 2016;126(3):560-565.
62.
DubalPMBhojwaniAPatelTD, et al. Squamous cell carcinoma of the maxillary sinus: a population-based analysis. Laryngoscope. 2016;126(2):399-404.
63.
LeeCHHurDGRohH-J, et al. Survival rates of sinonasal squamous cell carcinoma with the new AJCC staging system. Arch Otolaryngol Neck Surg. 2007;133(2):131-134.
64.
BhattacharyyaN.Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Neck Surg. 2002;128(9):1079-1083.
OliverJRLiebermanSMTamMM, et al. Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma. Cancer. 2020;126(7):1413-1423.
67.
BishopJAGuoTWSmithDF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2):185-192.
68.
FrieslandSMellinHMunck-WiklandE, et al. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma—relation to radiotherapy response and survival. Anticancer Res. 2001;21(1B):529-534.
69.
SiskEASoltysSGZhuSFisherSGCareyTEBradfordCR.Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck. 2002;24(9):841-849.
70.
MarurSD’SouzaGWestraWHForastiereAA.HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-789.
71.
WangMBLiuIYGornbeinJANguyenCT.HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Neck Surg. 2015;153(5):758-769.
72.
KawakamiHOkamotoITeraoK, et al. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Med. 2013;2(6):933-941.
73.
TorabiSJSpockTCardosoB, et al. Margins in sinonasal squamous cell carcinoma: predictors, outcomes, and the endoscopic approach. Laryngoscope. 2020;130(6):E388-E396.
74.
FornelliRAFedokFGWilsonEPRodmanSM.Squamous cell carcinoma of the anterior nasal cavity: a dual institution review. Otolaryngol Neck Surg. 2000;123(3):207-210.
75.
KimSAChungY-SLeeBJ.Recurrence patterns of sinonasal cancers after a 5-year disease-free period. Laryngoscope. 2019;129(11):2451-2457.
76.
JafariAShenSAQualliotineJROroscoRKCalifanoJADeCondeAS.Impact of margin status on survival after surgery for sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2019;9(10):1205-1211.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
